Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Federal Trade Commission
Harvard Business School

Generated: December 13, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Lamotrigine patents expire, and when can generic versions of Lamotrigine launch?

Lamotrigine is a drug marketed by Alembic Pharms Ltd, Aurobindo Pharma, Dr Reddys Labs Ltd, Glenmark Pharms Ltd, Jubilant Generics, Mylan, Sandoz, Taro, Teva, Watson Labs, Zydus Pharms Usa Inc, Actavis Elizabeth, Anchen Pharms, Handa Pharms Llc, Par Pharm, Torrent Pharms Ltd, Wockhardt Ltd, Impax Labs Inc, Sciegen Pharms Inc, Actavis Totowa, Alkem Labs Ltd, Apotex Inc, Cipla Ltd, Glenmark Generics, Hikma Pharms, Jubilant Cadista, Lupin Ltd, Mylan Labs Ltd, Pharmascience Inc, Roxane, Taro Pharm Inds, Torrent Pharms, Unichem Labs Ltd, Wockhardt, and Zydus Pharms Usa. and is included in forty-five NDAs.

The generic ingredient in LAMOTRIGINE is lamotrigine. There are thirty-two drug master file entries for this compound. Sixty-six suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the lamotrigine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Actavis TotowaLAMOTRIGINElamotrigineTABLET;ORAL078669-001Apr 8, 2011DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Glenmark GenericsLAMOTRIGINElamotrigineTABLET;ORAL090169-002May 12, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Handa Pharms LlcLAMOTRIGINElamotrigineTABLET, EXTENDED RELEASE;ORAL202887-001Jun 17, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Anchen PharmsLAMOTRIGINElamotrigineTABLET, EXTENDED RELEASE;ORAL201374-003Dec 26, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
WockhardtLAMOTRIGINElamotrigineTABLET;ORAL078982-003Jan 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncLAMOTRIGINElamotrigineTABLET;ORAL078625-003Jan 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lupin LtdLAMOTRIGINElamotrigineTABLET;ORAL078691-003Jun 1, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Taro Pharm IndsLAMOTRIGINElamotrigineTABLET;ORAL078525-002Jan 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmLAMOTRIGINElamotrigineTABLET, EXTENDED RELEASE;ORAL201791-005Jan 18, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Jubilant CadistaLAMOTRIGINElamotrigineTABLET;ORAL079132-004Jan 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: